Apyx Medical Corporation
US ˙ NasdaqGS ˙ US03837C1062

SecurityAPYX / Apyx Medical Corporation
InstitutionRoyce & Associates Lp
ManagerChuck Royce
Latest Disclosed Ownership2,443,035 shares
Ownership 5.95%
Royce & Associates Lp ownership in APYX / Apyx Medical Corporation

2026-01-20 - Royce & Associates Lp has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,443,035 shares of Apyx Medical Corporation (US:APYX). This represents 5.95 percent ownership of the company. In their previous filing dated 2024-10-15 , Royce & Associates Lp had reported owning 2,582,490 shares, indicating a decrease of -5.40 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2026-01-20 2026-01-20 13G/A 2,582,490 2,443,035 -5.40 5.95 -20.13
2024-10-15 2024-10-15 13G/A 2,158,900 2,582,490 19.62 7.45 19.58
2024-01-23 2024-01-23 13G/A 2,158,900 6.23
2024-01-23 2024-01-23 13G 2,158,900 6.23

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F APYX MEDICAL COM 03837C106 2,611,224 168,189 6.88 9,635 12.69 0.0951
2026-02-09 2025-12-31 13F APYX MEDICAL COM 03837C106 2,443,035 -31,364 -1.27 8,551 61.47 0.0867
2025-11-12 2025-09-30 13F APYX MEDICAL COM 03837C106 2,474,399 34,696 1.42 5,295 -3.53 0.0528
2025-08-11 2025-06-30 13F APYX MEDICAL COM 03837C106 2,439,703 -85,764 -3.40 5,489 58.69 0.0563
2025-05-06 2025-03-31 13F APYX MEDICAL COM 03837C106 2,525,467 -89,902 -3.44 3,460 -16.29 0.0375
2025-02-10 2024-12-31 13F APYX MEDICAL COM 03837C106 2,615,369 32,879 1.27 4,132 29.04 0.0383
2024-11-06 2024-09-30 13F APYX MEDICAL COM 03837C106 2,582,490 85,267 3.41 3,202 -4.30 0.0291
2024-08-13 2024-06-30 13F APYX MEDICAL COM 03837C106 2,497,223 60,564 2.49 3,346 1.00 0.0313
2024-05-13 2024-03-31 13F APYX MEDICAL COM 03837C106 2,436,659 277,759 12.87 3,314 -41.43 0.0296
2024-02-12 2023-12-31 13F APYX MEDICAL COM 03837C106 2,158,900 149,300 7.43 5,656 -12.04 0.0522
2023-11-09 2023-09-30 13F APYX MEDICAL COM 03837C106 2,009,600 406,624 25.37 6,431 -20.24 0.0655
2023-08-07 2023-06-30 13F APYX MEDICAL COM 03837C106 1,602,976 145,759 10.00 8,063 92.14 0.0783
2023-05-23 2023-03-31 13F/A-1 APYX MEDICAL COM 03837C106 1,457,217 658,749 82.50 4,197 124.63 0.0420
2023-05-04 2023-03-31 13F APYX MEDICAL COM 03837C106 1,457,217 658,749 4 0.0420
2023-05-23 2022-12-31 13F/A-1 APYX MEDICAL COM 03837C106 798,468 -85,800 -9.70 1,868 -52.95 0.0196
2023-02-13 2022-12-31 13F APYX MEDICAL COM 03837C106 798,468 -85,800 2 0.0195
2022-11-03 2022-09-30 13F APYX MEDICAL COM 03837C106 884,268 415,000 88.44 3,970 44.36 0.0449
2022-08-04 2022-06-30 13F APYX MEDICAL COM 03837C106 469,268 6,800 1.47 2,750 -8.94 0.0283
2022-05-05 2022-03-31 13F APYX MEDICAL COM 03837C106 462,468 -11,600 -2.45 3,020 -50.31 0.0256
2022-02-07 2021-12-31 13F APYX MEDICAL COM 03837C106 474,068 -69,732 -12.82 6,078 -19.30 0.0454
2021-11-10 2021-09-30 13F APYX MEDICAL COM 03837C106 543,800 -15,000 -2.68 7,532 30.74 0.0563
2021-08-06 2021-06-30 13F APYX MEDICAL COM 03837C106 558,800 0 0.00 5,761 6.72 0.0396
2021-05-10 2021-03-31 13F APYX MEDICAL COM 03837C106 558,800 0 0.00 5,398 34.18 0.0363
2021-02-08 2020-12-31 13F APYX MEDICAL COM 03837C106 558,800 0 0.00 4,023 52.85 0.0332
2020-11-12 2020-09-30 13F APYX MEDICAL COM 03837C106 558,800 204,900 57.90 2,632 34.01 0.0284
2020-08-07 2020-06-30 13F APYX MED COM 03837C106 353,900 -37,131 -9.50 1,964 39.89 0.0216
2020-05-12 2020-03-31 13F APYX MED COM 03837C106 391,031 -120,784 -23.60 1,404 -67.58 0.0191
2020-02-06 2019-12-31 13F APYX MED COM 03837C106 511,815 45,900 9.85 4,330 37.29 0.0387
2019-11-13 2019-09-30 13F APYX MED COM 03837C106 465,915 113,400 32.17 3,154 33.14 0.0292
2019-08-12 2019-06-30 13F APYX MED COM 03837C106 352,515 -402,900 -53.33 2,369 -50.30 0.0214
2019-05-09 2019-03-31 13F APYX MED COM 03837C106 755,415 60,415 8.69 4,767 5.84 0.0403
2019-02-11 2018-12-31 13F BOVIE MEDICAL COM 10211F100 695,000 -15,000 -2.11 4,504 -10.65 0.0404
2018-11-13 2018-09-30 13F BOVIE MEDICAL COM 10211F100 710,000 0 0.00 5,041 63.24 0.0348
2018-08-09 2018-06-30 13F BOVIE MEDICAL COM 10211F100 710,000 23,400 3.41 3,088 51.45 0.0214
2018-05-14 2018-03-31 13F BOVIE MEDICAL COM 10211F100 686,600 28,600 4.35 2,039 19.17 0.0143
2018-02-09 2017-12-31 13F BOVIE MEDICAL COM 10211F100 658,000 658,000 1,711 0.0114
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.